Clinical Trial Update: A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for MK0653A (ezetimibe plus simvastatin) in hypercholesterolemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• MK0653A (Ezetimibe (+) Simvastatin) (ezetimibe/simvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED